The San Antonio Breast Cancer Symposium® recognizes that satellite symposia are arranged in conjunction with the scheduled Symposium dates as a convenience to the target audience in attendance.
Satellite Educational Symposia for SABCS 2025 will take place at the San Antonio Marriott Rivercenter. These are not official programs of SABCS. Satellite Educational Symposia are autonomous, CME-accredited events that are held as an adjunct to SABCS and are supported by an organization other than SABCS. Satellite Educational Symposia go through a rigorous approval process and are evaluated for their ability to provide educational content distinct from and/or that enhances the content provided by the official SABCS scientific program. There is no cost to attend these sessions, but space is limited. Please register below.
Please note: All presentations at the SABCS meeting represent the opinions of the presenter and do not represent the position or the opinion of SABCS or its members.
2025 Schedule
Monday, December 8: 7:00-10:00 PM
Medical Crossfire®: From Frontline to Heavily Pretreated HR+/HER2- Metastatic Breast Cancer—Expert Perspectives on Optimizing the Expanding Treatment Armamentarium
Program Faculty: Erika P. Hamilton, MD; Guiseppe Curigliano, MD, PhD; V.K. Gadi, MD, PhD; Jason Aboudi Mouabbi, MD
Location: San Antonio Marriott Rivercenter, Salons C-E
This symposium is sponsored by Physicians’ Education Resource, LLC (PER) and is supported by grants from AstraZeneca, BioNTech, Genentech, Inc., and Stemliine Therapeutics, Inc. This is not an official program of SABCS.
Show Me the Data™: Personalizing First-Line and Maintenance Therapy in HER2+ Metastatic Breast Cancer to Extend Survival and Elevate Quality of Life
Program Faculty: Rena Callahan, MD; Sara A. Hurvitz, MD, FACP; Michelle Melisko, MD; Paolo Tarantino, MD, PhD
Location: San Antonio Marriott Rivercenter, Salons ABF
This symposium is sponsored by Physicians Education Resource, LLC (PER) and is supported by a grant from Pfizer. This is not an official program of SABCS.
Tuesday, December 9: 7:00-10:00 PM
Dialing Up Precision in HR+, HER2- MBC With New Endocrine Agents, Targeted Therapies, and Combinations: A Framework for Multifactorial Clinical Decisions
Program Faculty: Komal Jhaveri, MD, FACP; Giuseppe Curigliano, MD, PhD; Erica L. Mayer, MD, MPH; Nicholas Turner, MD, PhD, FRCP, FMedSci
Location: San Antonio Marriott Rivercenter, Salons ABF
This symposium is provided by PeerView Institute for Medical Education (PVI) and is supported by grants from AstraZeneca; Genentech, a member of the Roche Group; Lilly, and Stemline Therapeutics, a Menarini Company Group. This is not an official program of SABCS.
Medical Crossfire®: Mastering the Nuances of Early-Stage HR+/HER2- Breast Cancer: Expert Perspectives on Applying Modern Treatment Paradigms
Program Faculty: Tiffany A. Traina, MD, FASCO; Kevin Kalinsky, MD, MS; Mark E. Robson, MD; Rebecca Shatsky, MD
Location: San Antonio Marriott Rivercenter, Salons C-E
This symposium is sponsored by Physicians Education Resource, LLC (PER) and is supported by grants from AstraZeneca & Merck Sharp & Dohme Corp. This is not an official program of SABCS.
Cases from the Community—Investigators Discuss the Role of Antibody-Drug Conjugates in the Management of Triple-Negative and HR-Positive Metastatic Breast Cancer
Moderator: Neil Love, MD
Program Faculty: Javier Cortés, MD, PhD; Rita Nanda, MD; Professor Peter Schmid, FRCP, MD, PhD; Priyanka Sharma, MD
Location: San Antonio Marriott Rivercenter, Salons H-L
This symposium is sponsored by Research To Practice and is supported by educational grants from Gilead Sciences Inc and Helsinn Therapeutics (US) Inc. This is not an official program of SABCS.
Extending Efficacy: New Approaches for Endocrine-Resistant HR+/HER2- Advanced Breast Cancer
Program Faculty: Sara A. Hurvitz, MD, FACP (Chair); Manali Bhave, MD; Willaim J. Gradishar, MD; Marla Lipsyc-Sharf, MD
Location: San Antonio Marriott Rivercenter, Salons G-M
This symposium is sponsored by The Phillips Group and is supported by a grant from Industry Celcuity, Inc. This is not an official program of SABCS.
Wednesday, December 10: 7:00-10:00 PM
Medical Crossfire®: The Who, When, and How of TROP2-Targeting, ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer
Program Faculty: Hope S. Rugo, MD; Alison K. Conlin, MD; Marleen Kok, MD, PhD; Heather McArthur, MD, MPH
Location: San Antonio Marriott Rivercenter, Salons CDE
This Symposium is sponsored by Physicians’ Education Resource (PER) and is supported by grants from AstraZeneca, BioNTech, Daiichi Sankyo, Inc., and Merck Sharp & Dohme Corp. This is not an official program of SABCS.
Key Steps to Success with CDK4/6 Inhibition in Early Through Metastatic HR+, HER2- Breast Cancer: Stratification, Selection, Sequencing, and Specialty Management
Program Faculty: Sara A. Hurvitz, MD, FACP; Kamel Abou Hussein, MD; Carlos H. Barrios, MD; Eleonora Teplinsky, MD, FASCO
Location: San Antonio Marriott Rivercenter, Salons ABF
This symposium is provided by PeerView Institute for Medical Education (PVI) and is supported by the grants from Novartis Pharmaceuticals Corporation and Lilly. This is not an official program of SABCS.
Cases from the Community: Investigators Discuss the Optimal Management of Patients with HER2-Positive Breast Cancer
Moderator: Neil Love, MD
Program Faculty: Professor Giuseppe Curigliano, MD, PhD; Nadia Harbeck, MD, PhD; Ian E Krop, MD, PhD; Nancy U Lin, MD; Joyce O’Shaughnessy, MD
Location: San Antonio Marriott Rivercenter, Grand Ballroom H-L
This symposium is sponsored by Research To Practice, and supported by educational grants from AstraZeneca Pharmaceuticals LP, Daiichi Sankyo Inc, and Puma Biotechnology Inc. This is not an official program of SABCS.
Thursday, December 11: 7:00-9:30 PM
Forging New Paths With Earlier Use of ADCs in Breast Cancer: From Clinical Breakthroughs to Improved Outcomes
Program Faculty: Joyce O’Shaughnessy, MD; Javier Cortes, MD, PhD; Sibylle Loibl, MD, PhD; Paolo Tarantino, MD, PhD
Location: San Antonio Marriott Rivercenter, Salons ABF
This symposium is provided by PeerView Institute for Medical Education (PVI) and is supported by the grants from AstraZeneca and Daiichi Sankyo, Inc. This is not an official program of SABCS.
Medical Crossfire™: Navigating the Expanding Arsenal of Endocrine Therapies for HR+/HER2- Metastatic Breast Cancer—How Can PROTAC ER Degradation Shift the Standard?
Program Faculty: William J. Gradishar, MD, FACP, FASCO; Cynthia X. Ma, MD, PhD; Stephanie L. Graff, MD, FACP, FASCO
Location: San Antonio Marriott Rivercenter, Salons C-E
This symposium is sponsored by Physicians’ Education Resource and is supported by grants from Arvinas and Pfizer, Inc. This is not an official program of SABCS.
Cases from the Community: Investigators Discuss the Optimal Role of Endocrine-Based Therapy in the Management of Breast Cancer
Moderator: Neil Love, MD
Program Faculty: Angela DeMichele, MD, MSCE; Komal Jhaveri, MD, FACP, FASCO; Erica Mayer, MD, MPH, FASCO; Hope S Rugo, MD; Seth Wander, MD, PhD
Location: San Antonio Marriott Rivercenter, Salons H-L
This symposium is sponsored by Research To Practice and is supported by grants from Agendia Inc; Celcuity; Exact Sciences Corporation, Genentech, a member of the Roche Group; Hologic Inc, Lilly; and Stemline Therapeutics Inc. This is not an official program of SABCS.